Intrahepatic Cholangiocarcinoma (Record no. 28976)

MARC details
000 -LEADER
fixed length control field 02341nam a22002777a 4500
001 - CONTROL NUMBER
control field 20240930152720.0
003 - CONTROL NUMBER IDENTIFIER
control field 20240930152720.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240930153311.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240930b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-3-030-22257-4
International Standard Book Number 978-3-030-22258-1
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Timothy M. Pawlik
245 ## - TITLE STATEMENT
Title Intrahepatic Cholangiocarcinoma
Remainder of title Diagnosis and Management
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Columbus, OH USA |
Name of publisher, distributor, etc. Springer Nature Switzerland AG |
Date of publication, distribution, etc. 2019.
300 ## - PHYSICAL DESCRIPTION
Extent 221 Pages
Extent Includes References
490 ## - SERIES STATEMENT
Series statement https://doi.org/10.1007/978-3-030-22258-1
520 ## - SUMMARY, ETC.
Summary, etc. This book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC). It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care. The book was organized and written to aid the clinician’s understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients. Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included. An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options.<br/><br/>Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Cancer—Treatment, Medical / Clinical Medicine, Medical / Surgery / General, Surgery, Cancer -- Surgery, Hepatectomy.
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Jordan M. Cloyd
Fuller form of name Mary Dillhoff
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-3-030-22258-1 ">https://doi.org/10.1007/978-3-030-22258-1 </a>
Link text https://doi.org/10.1007/978-3-030-22258-1
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 09/30/2024   20240930152720.0 09/30/2024 09/30/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024